Skip to main content

Liothyronine Sodium

NDC 87063-081 · ASCLEMED USA INC.

Generic nameLiothyronine Sodium
Dosage formTABLET
RouteORAL
Active ingredient(s)LIOTHYRONINE SODIUM
Strength25 ug/1
Pharmacologic classTriiodothyronine [CS], l-Triiodothyronine [EPC]
Marketing categoryANDA

Packages

87063-081-00 — 1000 TABLET in 1 BOTTLE (87063-081-00)

87063-081-01 — 100 TABLET in 1 BOTTLE (87063-081-01)

87063-081-30 — 30 TABLET in 1 BOTTLE (87063-081-30)

87063-081-60 — 60 TABLET in 1 BOTTLE (87063-081-60)

87063-081-90 — 90 TABLET in 1 BOTTLE (87063-081-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68382-584 — Liothyronine sodium, 68788-7269 — Liothyronine Sodium, 70377-114 — Liothyronine sodium, 70377-115 — Liothyronine sodium, 70377-116 — Liothyronine sodium, 70771-1606 — Liothyronine sodium, 70771-1607 — Liothyronine sodium, 70771-1608 — Liothyronine sodium, 71205-150 — Liothyronine Sodium, 71335-0166 — Liothyronine Sodium, 71335-0341 — Liothyronine Sodium, 71335-1943 — Liothyronine sodium, 71335-1978 — Liothyronine sodium, 71335-2001 — Liothyronine sodium, 71335-9632 — Liothyronine Sodium, 75907-001 — Liothyronine Sodium, 75907-004 — Liothyronine Sodium, 75907-039 — Liothyronine Sodium, 87063-080 — Liothyronine Sodium, 87063-082 — Liothyronine Sodium, +30 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels